Obesity Raises Breast Cancer Recurrence Risk by 12%, says Penn State
Obesity increases a breast cancer survivor’s risk of disease recurrence by 12% and raises the mortality risk from the disease by 22%, according to a review of 173 studies published in the journal Breast Cancer and detailed by Penn State Health.
Key Clinical Takeaways:
- Patients with obesity face a 12% higher risk of breast cancer recurrence and a 22% higher risk of dying from the disease, per a review of 173 studies.
- Cancer survivors carrying excess weight show a 78% higher risk of developing a second obesity-related cancer, according to findings in JAMA Network Open.
- Treatment options range from lifestyle behavioral support and GLP-1 receptor agonists to bariatric procedures like sleeve gastrectomy and gastric bypass.
The 173-Study Review on Breast Cancer Recurrence and Obesity
Research published in the journal Breast Cancer analyzed 173 individual studies to evaluate the long-term oncological outcomes for breast cancer survivors carrying excess weight. The pooled data revealed that women with obesity experience a 12% higher risk of breast cancer returning. The data showed a 22% higher risk of dying from breast cancer compared to patients maintaining healthier body weights. A separate finding published in JAMA Network Open demonstrated that cancer survivors with obesity carry a 78% higher risk of developing a second obesity-related malignancy, including a secondary breast cancer occurrence.
Excess Fat Cells Secrete Hormones That Increase Cancer Risk
Excess adipose tissue functions actively as an endocrine organ. Emily Goddard, a bariatric surgeon, obesity medicine specialist and director of Penn State Health’s Surgical Weight Loss Program, explained the underlying pathology in material released during Breast Cancer Awareness Month. “Obesity is a metabolic disease where those extra fat cells secrete hormones and create a constant state of inflammation that can increase cancer risk,” Goddard stated. For hormone-driven malignancies like breast cancer, the accumulation of fat tissue alters sex hormones such as estrogen and estradiol to accelerate tumor growth. Postmenopausal women face an elevated vulnerability because, once the ovaries cease estrogen production, peripheral fat tissue becomes the body’s primary source of the hormone.
Treatment Pathways and Weight Loss Interventions After Cancer Recovery
Managing weight following treatments like breast surgery, chemotherapy, radiation, or hormone therapy requires individualized medical planning. Penn State Health outlines three primary clinical avenues for managing obesity in cancer survivors. Behavioral and lifestyle modification programs involve registered dietitians and clinical therapists to adjust nutrition and physical activity. Pharmacotherapy options include weight-loss medications such as GLP-1 agonists, which curb appetite and assist patients in reducing up to 20% of total body weight. For individuals with class 1 obesity (a body mass index, or BMI, of 30–35), treatment plans should take into account their overall health and may start with lifestyle changes and medication. These procedures include sleeve gastrectomy, gastric bypass, and single anastomosis duodenal-ileostomy with sleeve gastrectomy.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.